Synapse

← Petar Seferović

Papers by Petar Seferović

Page 3 · newest first

  1. HFA of the ESC Position Paper on the Management of LVAD-Supported Patients for the Non-LVAD Specialist Healthcare Provider Part 3: At the Hospital and DischargeESC Heart Failure · 2021
  2. Heart Failure Association of the European Society of Cardiology Position Paper on the Management of Left Ventricular Assist Device-Supported Patients for the Non-Left Ventricular Assist Device Specialist Healthcare Provider: Part 2: At the Emergency DepartmentESC Heart Failure · 2021
  3. HFA of the ESC Position Paper on the Management of LVAD Supported Patients for the Non LVAD Specialist Healthcare Provider Part 1: Introduction and at the Non-Hospital Settings in the CommunityESC Heart Failure · 2021
  4. Circulating heart failure biomarkers beyond natriuretic peptides: review from the Biomarker Study Group of the Heart Failure Association ( HFA ), European Society of Cardiology ( ESC )European Journal of Heart Failure · 2021
  5. Integration of imaging and circulating biomarkers in heart failure: a consensus document by the Biomarkers and Imaging Study Groups of the Heart Failure Association of the European Society of CardiologyEuropean Journal of Heart Failure · 2021
  6. Guidance on the management of left ventricular assist device (LVAD) supported patients for the non‐ LVAD specialist healthcare provider: executive summaryEuropean Journal of Heart Failure · 2021
  7. Preventing heart failure: a position paper of the Heart Failure Association in collaboration with the European Association of Preventive CardiologyEuropean Journal of Preventive Cardiology · 2021
  8. Multimodality imaging in patients with heart failure and preserved ejection fraction: an expert consensus document of the European Association of Cardiovascular ImagingEuropean Heart Journal - Cardiovascular Imaging · 2021
  9. Contrast-induced nephropathy in a patient with type 2 diabetes and coronary artery disease: a case reportJournal of International Medical Research · 2021
  10. The ‘Peptide for Life’ Initiative: a call for action to provide equal access to the use of natriuretic peptides in the diagnosis of acute heart failure across EuropeEuropean Journal of Heart Failure · 2021
  11. Cardiac, renal, and metabolic effects of sodium–glucose co‐transporter 2 inhibitors: a position paper from the European Society of Cardiology ad‐hoc task force on sodium–glucose co‐transporter 2 inhibitorsEuropean Journal of Heart Failure · 2021
  12. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failureEuropean Heart Journal · 2021
  13. Hypertensive disorders in women with peripartum cardiomyopathy: insights from the ESC EORP PPCM RegistryEuropean Journal of Heart Failure · 2021
  14. Heart Failure Association of the ESC, Heart Failure Society of America and Japanese Heart Failure Society Position statement on endomyocardial biopsyEuropean Journal of Heart Failure · 2021
  15. Patient profiling in heart failure for tailoring medical therapy. A consensus document of the Heart Failure Association of the European Society of CardiologyEuropean Journal of Heart Failure · 2021
  16. Embracing the unknown: risk stratification in heart failure with preserved ejection fraction with the EPYC scoreEuropean Journal of Preventive Cardiology · 2021
  17. The Heart Failure Association Atlas : Heart Failure Epidemiology and Management Statistics 2019European Journal of Heart Failure · 2021
  18. The management of secondary mitral regurgitation in patients with heart failure: a joint position statement from the Heart Failure Association (HFA), European Association of Cardiovascular Imaging (EACVI), European Heart Rhythm Association (EHRA), and European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESCEuropean Heart Journal · 2021
  19. Risk stratification and management of women with cardiomyopathy/heart failure planning pregnancy or presenting during/after pregnancy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum CardiomyopathyEuropean Journal of Heart Failure · 2021
  20. Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart FailureEuropean Journal of Heart Failure · 2021
  21. Pathophysiological Basis for Nutraceutical Supplementation in Heart Failure: A Comprehensive ReviewNutrients · 2021
  22. Expect the Unexpected in the Medical Treatment of Heart Failure with Reduced Ejection Fraction: between Scientific Evidence and Clinical WisdomInternational Journal of Heart Failure · 2021
  23. An ounce of prevention is worth a pound of cure: drugs and devices to prevent sudden cardiac death in heart failureEuropean Journal of Preventive Cardiology · 2020
  24. Insights Into Heart Failure Hospitalizations, Management, and Services During and Beyond COVID-19ESC Heart Failure · 2020
  25. Pathophysiological Basis for Nutraceutical Supplementation in Heart Failure: A Comprehensive Review2020
  26. Current use of cardiac magnetic resonance in tertiary referral centres for the diagnosis of cardiomyopathy: the ESC EORP Cardiomyopathy/Myocarditis RegistryEuropean Heart Journal - Cardiovascular Imaging · 2020
  27. Heart Failure Association of the European Society of Cardiology Update on Sodium–Glucose Co-Transporter 2 Inhibitors in Heart FailureEuropean Journal of Heart Failure · 2020
  28. Integration of a Palliative Approach into Heart Failure Care: A European Society of Cardiology Heart Failure Association Position PaperEuropean Journal of Heart Failure · 2020
  29. Role of Serum Biomarkers in Cancer Patients Receiving Cardiotoxic Cancer Therapies: A Position Statement from the Cardio-Oncology Study Group of the Heart Failure Association and the Cardio-Oncology Council of the European Society of CardiologyEuropean Journal of Heart Failure · 2020
  30. Prospective follow-up in various subtypes of cardiomyopathies: insights from the ESC EORP Cardiomyopathy RegistryEuropean Heart Journal - Quality of Care and Clinical Outcomes · 2020
  31. Self‐care of heart failure patients: practical management recommendations from the Heart Failure Association of the European Society of CardiologyEuropean Journal of Heart Failure · 2020
  32. Non-Insulin Antihyperglycaemic Drugs and Heart Failure: An Overview of Current Evidence from Randomized Controlled TrialsESC Heart Failure · 2020
  33. Role of Cardiovascular Imaging in Cancer Patients Receiving Cardiotoxic Therapies: A Position Statement on Behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC)European Journal of Heart Failure · 2020
  34. Sodium–Glucose Co-Transporter 2 Inhibitors in Heart Failure: Beyond Glycaemic Control. A Position Paper of the Heart Failure Association of the European Society of CardiologyEuropean Journal of Heart Failure · 2020
  35. Is Heart Failure Misdiagnosed in Hospitalized Patients with Preserved Ejection Fraction? From the European Society of Cardiology - Heart Failure Association EURObservational Research Programme Heart Failure Long-Term RegistryESC Heart Failure · 2020
  36. Epidemiology, Pathophysiology and Contemporary Management of Cardiogenic Shock – A Position Statement from the Heart Failure Association of the European Society of CardiologyEuropean Journal of Heart Failure · 2020
  37. Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology SocietyEuropean Journal of Heart Failure · 2020
  38. Management of Heart Failure Patients with COVID-19: A Joint Position Paper of the Chinese Heart Failure Association & National Heart Failure Committee and the Heart Failure Association of the European Society of CardiologyEuropean Journal of Heart Failure · 2020
  39. Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)European Heart Journal · 2020
  40. Clinical presentation, management, and 6-month outcomes in women with peripartum cardiomyopathy: an ESC EORP registryEuropean Heart Journal · 2020
  41. The Heart Failure Specialists of Tomorrow: A Network for Young Cardiovascular Scientists and CliniciansESC Heart Failure · 2020
  42. Acute Coronary Syndromes and Acute Heart Failure: A Diagnostic Dilemma and High-Risk Combination. A Statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of CardiologyEuropean Journal of Heart Failure · 2020
  43. Crouching tiger, hidden dragon: insulin resistance and the risk of atrial fibrillationEuropean Journal of Preventive Cardiology · 2020
  44. Association Between Loop Diuretic Dose Changes and Outcomes in Chronic Heart Failure: Observations from the ESC-EORP Heart Failure Long-Term RegistryEuropean Journal of Heart Failure · 2020
  45. A putative placebo analysis of the effects of sacubitril/valsartan in heart failure across the full range of ejection fractionEuropean Heart Journal · 2020
  46. Heart Failure Association of the European Society of Cardiology Quality of Care Centres Programme: Design and Accreditation DocumentEuropean Journal of Heart Failure · 2020
  47. The Heart Failure Association Atlas: Rationale, Objectives, and MethodsEuropean Journal of Heart Failure · 2020
  48. How to Diagnose Heart Failure with Preserved Ejection Fraction: The HFA–PEFF Diagnostic Algorithm: A Consensus Recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)European Journal of Heart Failure · 2020
  49. Oxidative stress and inflammation in heart failure: The best is yet to comeEuropean Journal of Preventive Cardiology · 2020
  50. Evaluation of Kidney Function Throughout the Heart Failure Trajectory – A Position Statement from the Heart Failure Association of the European Society of CardiologyEuropean Journal of Heart Failure · 2020